As of 30 Sep 2025, 9 institutional investors reported holding 1,299,513 shares of NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1,299,513 | $22,235,865 | -$56,301 | $17.11 | 9 |
| 2025 Q2 | 1,303,835 | $10,430,849 | -$24,954 | $8.00 | 10 |
| 2025 Q1 | 1,306,973 | $12,322,274 | -$180,492 | $8.99 | 10 |
| 2024 Q4 | 1,320,515 | $18,754,055 | +$115,751 | $14.25 | 11 |
| 2024 Q3 | 1,331,215 | $9,317,371 | +$241,907 | $7.00 | 11 |
| 2024 Q2 | 1,296,671 | $11,487,041 | -$1,594,623 | $8.72 | 10 |
| 2024 Q1 | 1,439,010 | $15,885,834 | +$1,340,288 | $11.04 | 11 |
| 2023 Q4 | 1,569,132 | $4,909,805 | -$72,143 | $3.13 | 17 |
| 2023 Q3 | 1,538,913 | $2,877,086 | -$577,326 | $1.90 | 18 |
| 2023 Q2 | 1,884,490 | $3,937,717 | -$730,847 | $2.09 | 18 |
| 2023 Q1 | 2,231,947 | $4,118,388 | -$28,418 | $1.84 | 18 |
| 2022 Q4 | 2,281,964 | $1,913,061 | +$1,913,061 | $0.87 | 20 |
| 2022 Q3 | 0 | $0 | -$35,530 | $27.41 | 0 |
| 2022 Q2 | 17,000 | $35,530 | +$35,530 | $2.09 | 1 |